A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
ACTIVE_NOT_RECRUITING
Status
Conditions
- Advanced Salivary Gland Carcinoma
Interventions
- DRUG: SHR-A1811
- DRUG: SHR 3680 + leuprolide
- DRUG: SHR-A1921
- DRUG: SHR-A1811
Sponsor
Fudan University